Login / Signup

Multiple lineage switches in KMT2A rearranged infant leukemia, responsive to combination therapy with CPX-351 and inotuzumab.

Justin SperlazzaJonathan GaleottiGeorge HucksThomas B Alexander
Published in: Pediatric blood & cancer (2023)
Keyphrases
  • combination therapy
  • acute myeloid leukemia
  • bone marrow
  • cancer therapy
  • single cell
  • cell fate